Detalhe da pesquisa
1.
Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
Int J Mol Sci
; 22(16)2021 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445297
2.
PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis.
Curr Opin Nephrol Hypertens
; 29(2): 171-179, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815758
3.
Trans-Right-Ventricle and Transpulmonary MicroRNA Gradients in Human Pulmonary Arterial Hypertension.
Pediatr Crit Care Med
; 21(4): 340-349, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876555
4.
The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman.
Am J Respir Crit Care Med
; 201(5): 621-624, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769697
5.
Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 200(11): 1447-1450, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31437404
6.
Chronic TGF-ß1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells.
Am J Respir Cell Mol Biol
; 61(1): 121-123, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31259625
7.
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
Cardiovasc Res
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626311
8.
Transforming Growth Factor ß1- and Bone Morphogenetic Protein 2/PPARγ-regulated MicroRNAs in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 196(9): 1227-1228, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28653861
9.
Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis.
Front Cardiovasc Med
; 9: 862330, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35369312
10.
Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension.
Front Cardiovasc Med
; 8: 794549, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957265
11.
Emerging therapies for right ventricular dysfunction and failure.
Cardiovasc Diagn Ther
; 10(5): 1735-1767, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224787
12.
Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb.
Nat Commun
; 11(1): 1315, 2020 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32161256
13.
Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle.
J Mol Med (Berl)
; 97(10): 1427-1438, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338525
14.
PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
Sci Transl Med
; 10(438)2018 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695452
15.
PPARγ Links BMP2 and TGFß1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism.
Cell Metab
; 25(5): 1118-1134.e7, 2017 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467929
16.
Letter by Legchenko et al Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure".
Circ Heart Fail
; 14(12): e008503, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932370
17.
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.
Heart
; 102(5): 390-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869635